BN Business News
Add your company to Business Communicator →

Business · 12/10/2017Updated: 10/17/2026 · 1 min read

FDA Announces Draft Guidance for Developing Antiviral Drugs Against Respiratory Syncytial Virus Infection

Summary

The FDA has released a draft guidance to help pharmaceutical companies develop antiviral drugs for the prevention and treatment of RSV infections, a common cause of respiratory illness in infants and vulnerable populations.

Original source language: Federal Register — Food and Drug AdministrationOpen original release →

Explore insights

Business insights →